Pankaj Bhargava

Pankaj Bhargava currently serves as the Chief Executive Officer at āshibio, Inc. and holds the position of Executive Partner at MPM BioImpact. Additionally, Pankaj Bhargava is a Member of the Board of Directors for multiple organizations, including Firefly Bio, Tizona Therapeutics, Inc., and Presidio Graduate School. Pankaj Bhargava also contributes as a Clinical Assistant Professor at the University of California, San Francisco. Pankaj Bhargava's earlier experience includes roles as Co-Founder and Advisor at Medocity, Inc., and Vice President, Oncology Therapeutics at Gilead Sciences. Educational achievements encompass an Executive Education program at Harvard Business School and fellowships in Clinical Pharmacology and Medical Oncology from Georgetown University School of Medicine, complemented by a residency in Internal Medicine at Maimonides Medical Center. Pankaj Bhargava earned a medical degree from University College of Medical Sciences.